Rapafusyn Pharmaceuticals to Present at the H.C. Wainwright 28th Annual Global Investment Conference

BALTIMORE, Sept. 2, 2026 /PRNewswire/ -- Rapafusyn Pharmaceuticals, a leader in the discovery and development of non-degrading molecular glue therapeutics, today announced that Dr. Sean Hu, President and Chief Executive Officer of Rapafusyn Pharmaceuticals, will present a company overview...